Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1161420210240101017
Journal of Medicinal Food
2021 Volume.24 No. 10 p.1017 ~ p.1027
Momordica Charantia: A Review of Its Effects on Metabolic Diseases and Mechanisms of Action
Cortez-Navarrete Marisol

Villar Miriam Mendez-del
Ramos-Gonzalez Elsy Janeth
Perez-Rubio Karina G.
Abstract
The global rise in the prevalence of metabolic diseases such as diabetes, obesity, and dyslipidemia is a serious public health issue. The search for safe and effective complementary and alternative therapies to treat metabolic disorders is a key field of research. Momordica charantia (MC) is a tropical and subtropical vine of the Cucurbitaceae family used as a medicinal plant since ancient times. Although MC has been widely studied for its hypoglycemic potential, hypolipidemic and antiobesity effects have also been reported in preclinical studies and clinical trials. This study aims to review the metabolic effects of MC reported in clinical trials as well as its mechanisms of action.
KEYWORD
dyslipidemia, Momordica charantia, obesity, prediabetes, type 2 diabetes mellitus
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI)